Resistell is a antibiotic resistance test.
Resistell Ag has raised €6.5M across 2 funding rounds from 1 investor, most recently a Series A round in Jan 2020. Based in Basel, Switzerland; founded 2018; active in Healthtech. Data as of 6 Aug 2026.
Timing: dormant vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2020-01-15 | Series A | €3.3M | OCCIDENT | View deal → |
| 2020-01-01 | Other | €3.2M | OCCIDENT | View deal → |
